Medicare Enrolled
Dr. Mark Rubenstein, M.D.
Cardiovascular Disease · Boca Raton, FL
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubenstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubenstein
Dr. Mark Rubenstein is a cardiovascular disease specialist in Boca Raton, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rubenstein performed 10,274 Medicare services across 6,501 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubenstein received a total of $14,592 from 45 pharmaceutical and/or device companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubenstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in FL
$14,592 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 85150 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗10,274
Medicare services
Top 7% in FL for cardiovascular disease
6,501
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~541 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,397 | $95 | $132 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,671 | $11 | $15 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
789 | $28 | $37 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
750 | $148 | $203 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
750 | $64 | $83 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
719 | $20 | $29 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
603 | $88 | $118 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
396 | $17 | $23 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
388 | $23 | $31 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
338 | $41 | $95 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
305 | $49 | $73 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
304 | $344 | $449 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
211 | $105 | $138 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
186 | $121 | $176 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
119 | $118 | $159 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
48 | $44 | $58 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
40 | $57 | $81 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
40 | $106 | $149 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
38 | $21 | $26 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
34 | $16 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $141 | $185 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
28 | $10 | $12 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
28 | $18 | $24 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
23 | $16 | $21 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
23 | $11 | $14 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
16 | $19 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.2% high complexity
16.8% medium
67.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,592
Total received (2018-2024)
Avg $2,085/year across 7 years
Top 18% in FL for cardiovascular disease
45
Companies
802
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,250 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$342 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,601
2023
$1,974
2022
$2,307
2021
$1,562
2020
$1,311
2019
$2,207
2018
$2,629
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,009
Janssen Pharmaceuticals, Inc
$1,802
Amgen Inc.
$1,548
Abbott Laboratories
$1,281
PFIZER INC.
$1,118
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,063
AstraZeneca Pharmaceuticals LP
$845
Amarin Pharma Inc.
$797
SANOFI-AVENTIS U.S. LLC
$736
Braemar Manufacturing, LLC
$268
Merck Sharp & Dohme LLC
$264
Medtronic, Inc.
$261
E.R. Squibb & Sons, L.L.C.
$259
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$245
Kowa Pharmaceuticals America, Inc.
$224
Impulse Dynamics (USA) Inc.
$175
Philips Electronics North America Corporation
$175
HeartFlow, Inc.
$159
Boston Scientific Corporation
$156
Regeneron Healthcare Solutions, Inc.
$149
Allergan Inc.
$129
Merck Sharp & Dohme Corporation
$85
Philips North America LLC
$81
Bayer Healthcare Pharmaceuticals Inc.
$64
Kiniksa Pharmaceuticals, Ltd.
$62
CVRx, Inc.
$61
Kiniksa Pharmaceuticals International, plc
$54
Chiesi USA, Inc.
$54
Novo Nordisk Inc
$51
Lexicon Pharmaceuticals, Inc.
$51
iRhythm Technologies, Inc.
$49
Lundbeck LLC
$40
Alnylam Pharmaceuticals Inc.
$39
ZOLL Circulation Inc
$34
ARBOR PHARMACEUTICALS, INC.
$30
HEARTFLOW, INC.
$23
Kestra Medical Technology Services, Inc.
$21
Esperion Therapeutics, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
Medtronic Vascular, Inc.
$18
Astellas Pharma US Inc
$17
CHIESI USA, INC.
$15
GENZYME CORPORATION
$14
BOSTON SCIENTIFIC CORPORATION
$14
CARDIVA MEDICAL, INC.
$14
Top 3 companies account for 36.7% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (CM9) Amb Mon & Diag Und · AMPLATZER AMULET · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CLEVIPREX · CONFIRM RX · Cardiac Monitoring Suite · Cardiva VASCADE MVP VVCS 6-12F · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Evera · FABRAZYME · FARXIGA · FFRct · GALLANT · General - Therapies · INVOKANA · Inpefa · JARDIANCE · JOT DX · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MULTAQ · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QUADRA ALLURE MP · RESONATE · REVEAL LINQ · Repatha · Reveal LINQ · SOLIQUA · Temperature Management System · Unify Assura CRT Defibrillator · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Sierra Coronary Stent · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $142 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
259
Per 100K population
17.2
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rubenstein is an electrophysiology & remote specialist, with above-average Medicare volume (top 7% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rubenstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rubenstein performed 2,397 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubenstein receive payments from pharmaceutical companies?
Yes. Dr. Rubenstein received a total of $14,592 from 45 companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubenstein's costs compare to other cardiologists in Boca Raton?
Dr. Rubenstein's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Boca Raton
Browse cardiologists in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology